FindTrial
Sign In

The Impact of Nutritional and Metabolic Factors on Immunotherapy in Advanced Non-Small Cell Lung Cancer Patients: A Study Based on Multimodal Data

The Impact of Nutritional and Metabolic Factors on Immunotherapy in Advanced Non-Small Cell Lung Cancer Patients: A Study Based on Multimodal Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095568
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer (NSCLC)

Interventions

Normal nutritional and metabolic group:None
High-risk nutritional and metabolic:None

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older, regardless of gender. 2. Stage III-IV; 3. First-time treatment with PD-(L)1 inhibitors, with or without other treatments; 4. At least one efficacy evaluation; 5. Consent to participate in the study;

Exclusion criteria

Exclusion criteria: 1. Baseline nutritional and metabolic status cannot be assessed; 2. Received other immune checkpoint inhibitors such as CTLA-4 inhibitors, or CAR-T therap; 3. Refusal to participate in the study;

Design outcomes

Primary

MeasureTime frame
Progression-Free Survival (PFS);—

Secondary

MeasureTime frame
Overall Survival (OS);Objective Response Rate (ORR);Immune-Related Adverse Events (irAEs);Serious Adverse Event (SAE);Treatment-Related Adverse Events (TRAE);—

Countries

China

Contacts

Public ContactGuo hui

Xi'an Jiaotong University Second Affiliated Hospital

guohuihappy97@163.com+86 13572824106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026